high-dose methotrexate as cns prophylaxis in dlbcl
Published 4 years ago • 2.2K plays • Length 4:24Download video MP4
Download video MP3
Similar videos
-
1:34
molecular-guided treatment of b-cell lymphomas
-
7:45
results of phase iii ukall 2011 study: impact of high-dose methotrexate on cns relapse in all
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
2:06
odronextamab in car-t relapsed diffuse large b-cell lymphoma
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
10:45
how medbeds can transform healing for genetic conditions
-
5:00
getting started on methotrexate : what you should know
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
2:25
the future of car-t for the treatment of lymphoma
-
2:34
the effect of dose reduction of talquetamab in patients with r/r mm: results from monumental-1
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
0:54
zilovertamab vedotin in the treatment of mantle cell lymphoma
-
1:45
mechanism of action of bitopertin to treat patients with epp
-
1:03
10-day astx727 (decitabine/cedazuridine) with venetoclax in the treatment of r/r aml
-
2:12
addressing issues with t-cell therapies for hematologic malignancies
-
1:26
durable symptom improvement in ntd thalassemia treated with luspatercept in the beyond trial
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:48
an introduction to the maxilus study: the optimal dose of luspatercept in lr-mds
-
1:46
phase i study of costimulatory bispecific antibody ro7227166 combined with glofitamab in r/r b-nhl
-
1:02
the use of car-t cell products in a real-world setting
-
1:18
the role of cellular immunotherapies in the future treatment of hl